Systematic analysis of factors associated with progression and regression of ulcerative colitis in 918 patients

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2036|42|5|540-548

ISSN： 0269-2813

Source： ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol.42, Iss.5, 2015-09, pp. : 540-548

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Systematic review: the financial burden of surgical complications in patients with ulcerative colitis

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 11, 2015-06 ,pp. : 1066-1078

John Wiley & Sons Inc

Access to resources Recommend Favorite

Ulcerative colitis endoscopic index of severity is associated with long‐term prognosis in ulcerative colitis patients treated with infliximab

By  

DIGESTIVE ENDOSCOPY, Vol. 28, Iss. 6, 2016-09 ,pp. : 665-670

John Wiley & Sons Inc

Access to resources Recommend Favorite

Systematic review with meta‐analysis: infliximab and immunosuppressant therapy vs. infliximab alone for active ulcerative colitis

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 7, 2015-04 ,pp. : 603-612

John Wiley & Sons Inc

Access to resources Recommend Favorite

Systematic review with network meta‐analysis: comparative assessment of tofacitinib and biological therapies for moderate‐to‐severe ulcerative colitis

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 47, Iss. 4, 2018-02 ,pp. : 454-465

John Wiley & Sons Inc

Access to resources Recommend Favorite

Factors Associated with Increased Risk of Exacerbation and Hospital Admission in a Cohort of Ambulatory COPD Patients: A Multiple Logistic Regression Analysis

By  

Respiration, Vol. 67, Iss. 5, 2000-10 ,pp. : 495-501

Karger

Access to resources Recommend Favorite